Recombinant human thrombopoietin（Peking University People's Hospital）
重组人血小板生成素（北京大学人民医院）
Report date: 2022/12/05 20:00:54
Base Information
Drug NameRecombinant human thrombopoietin（Peking University People's Hospital）
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPeking University People'S Hospital
China Registration ClassN/A
Develop Information
Active CompaniesPeking University People'S Hospital
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksWikipedia